HR Execs on the Move

Inspyr Therapeutics

www.inspyrtx.com

 
Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.inspyrtx.com
  • 2511 N Loop 1604 W Suite 204 (3rd Floor)
    San Antonio, TX USA 78258
  • Phone: 210.479.8112

Executives

Name Title Contact Details

Similar Companies

B C Decker

B C Decker Inc. is a Hamilton, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aspenbio Pharma Inc

Aspenbio Pharma Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Castle Rock, CO. To find more information about Aspenbio Pharma Inc, please visit www.aspenbiopharma.com

Genalyte

Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.

Holy Redeemer Health System

Holy Redeemer Health System is committed to our mission to care, comfort and heal, and to providing excellent healthcare services to our community.

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).